All articles from EyeWorld.org on the topic of cataracts. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
The second Business of Refractive Cataract Surgery (BRiCS) Summit will take place October 3–5 in Chicago, Illinois, giving a new set of surgeon-implementor teams the opportunity to gain insights and resources to enhance their advanced-technology IOL practice.
Regardless of surgical experience level, iris prolapse is something that happens to all surgeons occasionally. As such, knowledge of the risk factors that could predispose a patient to iris prolapse, how to handle the event, and postop considerations are an important refresh from time to time.
New tools in surgical training are constantly improving teaching methods. In this issue’s YES Connect column, several physicians spoke about digital tools for surgical training and how these fit in with more traditional training approaches.
In his introduction to the Cataract section, Mitchell Weikert, MD, highlighted some of the valuable offerings at the ASCRS Annual Meeting and previewed the hot topics in cataract surgery covered in the issue.
Corneal edema after cataract surgery is expected to an extent, but as postop recovery stretches to 1 month or beyond, surgeons begin to treat the situation differently. Three surgeons discussed preop contributors, prevention, diagnosis, and treatment of prolonged corneal edema.
While true allergies to materials used during cataract surgery are uncommon, this is a topic that physicians may need to discuss with patients. Two physicians highlighted some of the key concerns they hear from patients and how they approach these to identify real allergies versus intolerances.
With its approval in 2017, many physicians have several years of lessons learned with the Light Adjustable Lens (LAL, RxSight). With the more recent commercial launch of the LAL+, which has a modified aspheric surface to extend depth of focus slightly, ophthalmologists have even more to talk about.
With great opportunity in the world of IOLs also comes a challenge: how to discuss these options efficiently in a targeted manner without overwhelming or causing confusion for the patient. EyeWorld spoke with three members of its Cataract Editorial Board to learn how they manage this discussion.
“Many of our ‘tried and true’ methods for managing ophthalmic disorders are being revisited, rethought, and updated as we leverage new insights into their underlying pathology … ,” said Cataract Editor Mitchell Weikert, MD, in his introduction, in which he also previewed the articles in the section.
➤ Positive topline Phase 3 data for presbyopia drop ➤ Topline results for oral therapy targeting geographic atrophy ➤ Positive topline results from Phase 2 sustained-delivery drug for DME ➤ Study assesses new virtual reality simulator for phaco ➤ ASCRS news and events